Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytomegalovirus infection

P Ljungman1, H Einsele

  • 1Huddinge University Hospital, Karolinska Institute, Sweden.

Current Opinion in Hematology
|November 1, 1994
PubMed
Summary

Advances in managing cytomegalovirus (CMV) infection after bone marrow transplants include new antiviral prophylaxis, T-cell immunoprophylaxis, and rapid diagnostics enabling preemptive therapy. However, CMV pneumonia treatment outcomes remain poor.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D.

Leukemia·2026
Same author

Molecular diagnostics in cancer patients with suspected respiratory mold infections.

Journal of clinical microbiology·2025
Same author

European Myeloma Network Group review and consensus statement on primary plasma cell leukemia.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Real-world analysis of teclistamab in 123 RRMM patients from Germany.

Leukemia·2024
Same author

Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myeloma.

Annals of hematology·2023
Same author

Tracking the progeny of adoptively transferred virus-specific T cells in patients posttransplant using TCR sequencing.

Blood advances·2022

Area of Science:

  • Infectious Diseases
  • Hematology
  • Immunology

Background:

  • Cytomegalovirus (CMV) infection poses a significant complication for allogeneic bone marrow transplant recipients.
  • Historically, CMV disease management has been challenging, impacting patient outcomes.

Purpose of the Study:

  • To review recent advancements in the prevention and treatment of CMV infection in bone marrow transplant patients.
  • To highlight the evolving strategies for managing CMV disease in this high-risk population.

Main Methods:

  • Review of current antiviral prophylaxis agents and their efficacy.
  • Discussion of immunoprophylaxis strategies, including adoptive T-cell therapy.
  • Evaluation of rapid diagnostic techniques like antigenemia assays and PCR for CMV DNA detection.
  • Analysis of preemptive therapy approaches based on early diagnosis.

Main Results:

  • Significant improvements in antiviral prophylaxis offer better protection against CMV infection.
  • Adoptive T-cell immunotherapy is emerging as a feasible immunoprophylaxis option.
  • Rapid diagnostic tools facilitate timely preemptive treatment strategies.
  • Despite advancements, the treatment of CMV pneumonia shows limited success, with approximately 50% survival even with combined ganciclovir and immunoglobulin therapy.

Conclusions:

  • Multiple new strategies have enhanced the management of CMV infection in bone marrow transplant recipients.
  • While prevention and early detection have improved, therapeutic outcomes for established CMV pneumonia require further development.

Related Experiment Videos